Literature DB >> 21057240

Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression.

Armando L Morera-Fumero, Pedro Abreu-Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21057240     DOI： 10.1097/JCP.0b013e3181fbbb7d

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  2 in total

1.  Agomelatine for Depression in Schizophrenia: A Case-Series.

Authors:  Jochen Mutschler; Nicolas Rüsch; Herdis Schönfelder; Uwe Herwig; Annette B Brühl; Martin Grosshans; Wulf Rössler; Heike Russmann
Journal:  Psychopharmacol Bull       Date:  2012-02-15

Review 2.  Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.

Authors:  Domenico De Berardis; Michele Fornaro; Nicola Serroni; Daniela Campanella; Gabriella Rapini; Luigi Olivieri; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Andrea De Bartolomeis; Alessandro Valchera; Giampaolo Perna; Monica Mazza; Marco Di Nicola; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.